Haemodynamic effects of sacubitril/valsartan in advanced heart failure

AIMS: The angiotensin receptor–neprilysin inhibitor (ARNI), sacubitril/valsartan, has been shown to be effective in treatment of patients with heart failure (HF), but limited data are available in patients with advanced disease. This retrospective observational study assessed the effects of ARNI tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentile, Piero, Cantone, Rosaria, Perna, Enrico, Ammirati, Enrico, Varrenti, Marisa, D'Angelo, Luciana, Verde, Alessandro, Foti, Grazia, Masciocco, Gabriella, Garascia, Andrea, Frigerio, Maria, Cipriani, Manlio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934977/
https://www.ncbi.nlm.nih.gov/pubmed/35064756
http://dx.doi.org/10.1002/ehf2.13755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934977/
https://www.ncbi.nlm.nih.gov/pubmed/35064756
http://dx.doi.org/10.1002/ehf2.13755

Ejemplares similares